Although the atypical antipsychotic agent clozapine has little propensity to induce hyperprolactinemia in humans it increases serum prolactin levels in the rat. In this study, the effects of clozapine and of some typical antipsychotic drugs on basal and dopamine-mediated prolactin secretion from cultured rat pituitary cells were compared. Despite being less potent than the other antipsychotic agents tested, clozapine reverted the effect of dopamine on prolactin secretion in vitro, This finding suggests that clozapine interferes with dopamine receptors in the pituitary gland. (C) 1997 The Italian Pharmacological Society.

Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells / Braghiroli, Laura; A., Ponzianelli; M., Fiani; DE FEO, Giuseppe; C. Y., Cheng; Mazzanti, Gabriela. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - STAMPA. - 35:3(1997), pp. 173-175. [10.1006/phrs.1996.0102]

Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells

BRAGHIROLI, Laura;DE FEO, Giuseppe;MAZZANTI, Gabriela
1997

Abstract

Although the atypical antipsychotic agent clozapine has little propensity to induce hyperprolactinemia in humans it increases serum prolactin levels in the rat. In this study, the effects of clozapine and of some typical antipsychotic drugs on basal and dopamine-mediated prolactin secretion from cultured rat pituitary cells were compared. Despite being less potent than the other antipsychotic agents tested, clozapine reverted the effect of dopamine on prolactin secretion in vitro, This finding suggests that clozapine interferes with dopamine receptors in the pituitary gland. (C) 1997 The Italian Pharmacological Society.
1997
cell culture; clozapine; dopamine; prolactin; rat
01 Pubblicazione su rivista::01a Articolo in rivista
Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells / Braghiroli, Laura; A., Ponzianelli; M., Fiani; DE FEO, Giuseppe; C. Y., Cheng; Mazzanti, Gabriela. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - STAMPA. - 35:3(1997), pp. 173-175. [10.1006/phrs.1996.0102]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/256989
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact